New eye drug shows promise in early safety trial for blinding disease
Disease control
Completed
This early-stage study tested a new drug called OLX10212 in 21 people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The main goal was to see if the eye injections are safe and tolerable. Researchers also looked for early signs that the drug migh…
Phase: PHASE1 • Sponsor: Olix Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 10:47 UTC